During the last decades a significant progress in the treatment of acu
te lymphoblastic leukemia (ALL) in children has been achieved. Accordi
ng to the data of some leading centers in this field current event-fre
e survival rate is as high as 80%. In the Republic of Belarus from Jul
y 1990 a total of 337 children (3 months to 16 years of age) received
chemotherapy according to the modified protocol ALL-BFM-90. According
to 6-year follow-up data, complete remission was achieved in 315(93.5%
) patients, 49(13.5%) children died at different stages of treatment.
Relapses developed in 42(12.5%) patients. 243(72.1%) patients survived
at the endpoint of the study in continuous complete remission, Event-
free survival rate was 68+/-3% for the whole group of patients. The in
troduction of the ALL-BFM-90 protocol of chemotherapy allowed to impro
ve significantly the outcomes of ALL children treatment. Further progr
ess may be achieved in cooperative trials.